|

RNA Transcription Modulator AU-409 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: AU 409, AU-409, AU409

Pipeline

Phase 1: 1

Top Sponsors

  • University of Southern California1

Indications

  • Liver Disease1
  • Advanced Cholangiocarcinoma1
  • Metastatic Malignant Neoplasm in the Liver1
  • Stage IV Hepatocellular Carcinoma AJCC v81
  • Stage III Hepatocellular Carcinoma AJCC v81

Los Angeles, California1 trial

AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease

Los Angeles County-USC Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.